Free tool
Healthcare stocks
We cover 53 companies in the Healthcare sector. The median market value in the group is $314.33M. Across the group, the median move over the past trading day is +1.08%. 90% of the 51 with a 200-day average trade above it. Price change over the past year runs from −37.0% to +134.3% across the middle 80 percent of the group, with a median of +9.5%. Across the group, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
53 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | 717.90 EUR | +25.00% | +8.96% | −5.91% |
| 0QF.DE | Moderna, Inc. | 136.12 EUR | +181.04% | +417.17% | +550.51% |
| BOX.DE | Becton, Dickinson and Company | 168.80 EUR | +23.08% | +2.38% | +1.73% |
| QTS.DE | IQVIA Holdings Inc. | 222.10 EUR | +19.34% | +15.23% | −4.04% |
| ILU.DE | Illumina, Inc. | 193.08 EUR | +13.91% | +69.73% | +129.80% |
| 22UA.DE | BioNTech SE | 100.00 EUR | +23.08% | +21.29% | +14.09% |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% |
| GE9.DE | Genmab A/S | 294.20 EUR | +17.26% | +9.78% | −11.12% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% |
| AMBU-B.CO | Ambu A/S | 78.40 DKK | +8.59% | −9.10% | −19.13% |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% |
| BAVA.CO | Bavarian Nordic A/S | 218.20 DKK | +23.42% | +13.17% | −7.97% |
| ONT.L | Oxford Nanopore Technologies plc | 183.00 GBP | +62.81% | +42.97% | −2.24% |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% |
| REG1V.HE | Revenio Group Oyj | 14.78 EUR | +16.56% | −33.12% | −38.54% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.45 EUR | +31.64% | +51.39% | +75.81% |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% |
| AOTI.L | AOTI, Inc. | 142.50 GBP | +35.71% | +418.18% | +159.09% |
| MRC.WA | Mercator Medical S.A. | 60.40 PLN | +18.43% | +52.53% | +35.88% |
| BICO.ST | BICO Group AB (publ) | 19.92 SEK | +36.25% | −1.19% | −17.00% |
| PAX.ST | Paxman AB (publ) | 57.50 SEK | +26.37% | +2.68% | −21.45% |
| XI3.F | Bioceltix S.A. | 20.40 EUR | +7.59% | −16.22% | −28.67% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| ALECR.PA | Eurofins-Cerep SA | 17,700.00 EUR | +8.59% | −0.56% | −3.80% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | 13.70 SEK | +13.41% | −28.65% | −11.27% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +10.38% | +16.53% | +17.03% |
| AREC.L | Arecor Therapeutics plc | 66.00 GBP | +3.94% | −22.35% | +3.94% |
| SIGHT.PA | GenSight Biologics S.A. | 0.12 EUR | +46.83% | +5.61% | −25.31% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | 1.75 SEK | +32.27% | −13.13% | −44.31% |
| RENX.L | Renalytix Plc | 4.30 GBP | +62.26% | −27.12% | −26.50% |
| RUA.L | RUA Life Sciences plc | 28.00 GBP | +9.80% | +103.64% | +130.93% |
| ALTAO.PA | Aton | 0.02 EUR | +94.12% | +182.86% | +153.85% |
| ICO.ST | Iconovo AB (publ) | 1.26 SEK | +26.00% | +12.50% | −52.09% |
| CRTX.L | CRISM Therapeutics Corporation | 11.50 GBP | +21.05% | +15.00% | +9.52% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| FDBK.L | Feedback plc | 6.85 GBP | +13.22% | −36.28% | −48.30% |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% |
| BSLN.SW | Basilea Pharmaceutica AG | 65.30 CHF | +24.62% | +19.82% | +40.88% |
| SKAN.SW | SKAN Group AG | 65.70 CHF | +9.87% | +26.45% | +6.80% |
| SOON.SW | Sonova Holding AG | 245.00 CHF | +10.16% | +17.62% | +6.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.